On February 1, The Centers for Medicare and Medicaid Services (CMS) released the final rule for the National Physician Payment Transparency Progam: Open Payments, or “The Sunshine Act.” The new rule requires that manufacturers of drugs, medical supplies, devices, and biologicals covered by Medicare, Medicaid, or the Children’s Health Insurance Program (CHIP) to report payment or other transfers of value to physicians and teaching hospitals to CMS. This data will then be posted to a public website. The rule also requires that manufacturers and group purchasing organizations (GPOs) disclose physician ownership or investment interest to CMS.
Data collection will begin on August 1, 2013, with appropriate manufacturers and GPOs reporting payment information for August 2013 to December 2013 by March 31, 2014. CMS will release this data on a public website by September 30, 2014. Required organizations, physicians, and teaching hospitals will have an opportunity to review and corrected reported data prior to its publication, and CMS is developing an electronic filing system to facilitate the data collection process.
ASH is currently reviewing the new rule. The Society had submitted comments on its proposed rule. ASH had advocated that the rule not negatively impact continuing medical education programs. As the rule is implemented, ASH will work to make sure its members have accurate information about the new reporting process.